Amylyx Pharmaceuticals Investor Lawsuit: Overstated Drug Potential?
Class action lawsuit filed against Amylyx Pharmaceuticals for securities violations, alleging overstated drug prospects and failure to disclose key information. ...
- Latest
- Trending
Class action lawsuit filed against Amylyx Pharmaceuticals for securities violations, alleging overstated drug prospects and failure to disclose key information. ...
Roadzen Inc. reports impressive Q3 revenue growth of 372% but also discloses a net loss of $30.57 million. The company's ...
Lattice Semiconductor reports strong financial performance for fiscal year 2023, with a 12% increase in revenue, impressive gross margin expansion, ...
Victory Capital Holdings' assets under management (AUM) decreased slightly to $165.5 billion as of January 2024. The firm offers diversified ...
Hudson Pacific Properties, Inc. reports decline in net income for Q4 2023 due to asset sales and decrease in total ...
Stock futures dip as investors await inflation report release. ZoomInfo beats expectations, Arista Networks and Cadence Design Systems decline. S&P ...
Medical technology company TransMedics Group, Inc. is set to release its Q4 and full year 2023 financial results, highlighting its ...
The opening of Red Mile Gaming's sportsbook in Kentucky allowed residents to legally bet on the Super Bowl for the ...
Safehold Inc. reports positive financial results for Q4 and FY2023, with increased revenue, adjusted net income, and an upgraded credit ...
Federal Realty Investment Trust reports a decrease in net income for 2023, but shows growth in funds from operations and ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.